Donovan v. GMO-Z.com Trust Company, Inc., --- F.Supp.3d ----,
2025 WL 522503, No. 23 Civ. 8431 (AT) (S.D.N.Y. Feb. 17, 2025)
Plaintiffs sued GMO Trust, alleging that it violated federal
securities laws and NY state consumer protection laws in connection with the
“offer” of a digital asset known as “GYEN,” sold as a “stablecoin.” The court
found that GYEN wasn’t a security, but allowed the NY and California claims to
proceed. (Claims against Coinbase have
been sent to arbitration.)
GMO Trust touted GYEN as a fiat-collateralized stablecoin—that
is, one unit of the stablecoin is backed by one unit of fiat currency, here the
Japanese yen. GMO Trust retains for itself any interest generated by the bank
accounts where it deposits customer collateral, and it may receive monetary
benefits from third-party exchanges as consideration for agreeing to list GYEN
on their platforms.
Its Whitepaper on its website touted GYEN as “a global
currency solution” that can “virtually eliminate [the] volatility” associated
with traditional digital assets such as Bitcoin “while still benefitting from
the advantages of digital assets, such as high transaction speeds matched with
low costs.” GMO Trust advertised and linked to various “partner” exchanges,
including Binance and Coinbase. It allegedly consistently maintained in its
promotional materials that purchasers could “always redeem 1 GYEN for 1 JPY ...
directly with GMO Trust” and on any third-party exchanges that listed the
digital asset.
GYEN launched in March 2021, and there was a lot of price
movement. Plaintiffs bought at elevated prices and lost 90% or even 99% of their
purchase prices as the price of GYEN returned to its yen peg. For example, “GYEN
purchasers whose orders on Binance took time to fill, or who mistakenly bought
GYEN when the price on Binance was untethered from the value of JPY, lost as
much as 99 percent of their purchase value within hours.” Some of this occurred
when exchanges were restricting the ability of customers to trade GYEN in order
to deal with rapid fluctuations.
Whether GYEN was a “security” is outside my wheelhouse, so I’ll
just report the court’s top-line conclusion: no (specific to the stablecoin
context).
However, it was reasonably likely that there would still be
CAFA jurisdiction over the state law claims, to which the court turned:
Plaintiffs allege that GMO Trust
targeted consumers with statements and advertisements representing that GYEN
would always remain pegged to the value of a historically stable fiat currency;
omitted the risk that the asset’s value could become untethered from JPY on
certain of GMO Trust’s “partner” platforms; and continued to make such
representations and omissions even after the price of GYEN on Binance
temporarily untethered from the value of JPY in May 2021. Indeed, Plaintiffs
allege that GMO Trust not only omitted the risk that the price of GYEN could
become untethered on third-party platforms, but it affirmatively stated that
consumers would “always” be able to purchase GYEN at a one-to-one value with
JPY on GMO Trust’s “partner” exchanges.
They also sufficiently alleged that these statements were
objectively misleading, deceptive, and false because the value of GYEN in fact
could—and allegedly did—become untethered from the value of JPY on third-party
exchanges, and fluctuated over 200% against the dollar in one period. “Given
that GMO Trust held GYEN out to consumers as a ‘stable’ counterweight to the
extreme volatility of the digital asset market, and held itself out as a
regulated and licensed entity offering a product backed by fiat currency held
in FDIC-insured U.S. bank accounts and monitored by independent auditors, a
reasonable consumer, acting reasonably in the circumstances, could have been
misled or deceived by GMO Trust’s statements, acts, practices, omissions, and
advertisements.”
As to California law, the court declined to require plaintiffs
to meet Rule 9(b)’s heightened pleading standard, because the UCL’s “fraud”
prong is not the same as common law fraud—it has lower standards. Unfairness
claims also survived.
No comments:
Post a Comment